JewishStatusOpen the app

FrontRow · Aug 4, 2026

FrontRow — photo status

Procter & Gamble is buying supplement brand Thorne for $3.8 billion, CEO Shailesh Jejurikar said on CNBC’s “Squawk on the Street.” The acquisition, which is set to be announced Tuesday, is a bid for P&G to grow its health and wellness division. The consumer goods giant already owns several other supplements brands, like Metamucil, Align Probiotic and New Chapter vitamins, which are housed within a broader healthcare division that includes Oral-B and Vicks. “We are really happy with the asset itself,” Jejurikar told CNBC’s Sara Eisen. “It’s a really well-run operation, and it’s been around for a long time.”

Procter & Gamble is buying supplement brand Thorne for $3.8 billion, CEO Shailesh Jejurikar said on CNBC’s “Squawk on the Street.” The acquisition, which is set to be announced Tuesday, is a bid for P&G to grow its health and wellness division. The consumer goods giant already owns several other supplements brands, like Metamucil, Align Probiotic and New Chapter vitamins, which are housed within a broader healthcare division that includes Oral-B and Vicks. “We are really happy with the asset itself,” Jejurikar told CNBC’s Sara Eisen. “It’s a really well-run operation, and it’s been around for a long time.”

Watch in the app All of FrontRow's statuses

More from FrontRow